Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil dose requirement under low vs high tidal volume during rhinoplasty
IRCT20200825048515N71Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remifentanil in rhinoplasty (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Heart beat and 1 more. Started Oct 2023; status: completed.
02
Drugs
remifentanil
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20200825048515N71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N71.